US Patent Issued to Children's National Medical Center on March 31 for "Targeted T-cell therapy for treatment of multiple myeloma" (Maryland Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,292, issued on March 31, was assigned to Children's National Medical Center (Washington).

"Targeted T-cell therapy for treatment of multiple myeloma" was invented by Catherine Mary Bollard (Bethesda, Md.), Conrad Russell Y. Cruz (Bethesda, Md.) and Patrick Hanley (Hyattsville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are activated adoptive T-cell compositions targeting plasma cell dyscrasias such as multiple myeloma and methods of treating plasma cell dyscrasias such as multiple myeloma using such compositions. The T-cell compositions of the present disclosure are activated against a select group of antigens associated wit...